DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Oura announced the rollout of two new features, Meals and Glucose, to give users a clearer view of how daily behaviors affect ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...

In an exclusive interview, Nick Jonas shares what it's like to have his brothers' support as he takes on solo projects, like ...

DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins. Check out why I am lowering my rating on DXCM from buy to hold.

Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...

I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...

DexCom Inc. closed 38.36% below its 52-week high of $132.26, which the company reached on May 17th.

DexCom Inc. closed 39.31% below its 52-week high of $132.26, which the company reached on May 17th.

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...

Ōura, maker of a health-monitoring smart ring, announced that it will use AI to track and analyze two new metabolic health features: meals and glucose.